To assess the effect of TACR1 inhibition on neuroblastoma cell viability, we treated cells in vitro with the water soluble aprepitant analog, fosaprepitant, and assessed cell viability relative to untreated control cultures in MTT assays. The gene discussed is TACR1; the disease is neuroblastoma.